Bessemer Group Inc. Raises Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bessemer Group Inc. boosted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 24.9% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 416,522 shares of the medical equipment provider's stock after buying an additional 83,143 shares during the quarter. Bessemer Group Inc. owned approximately 0.12% of Intuitive Surgical worth $206,292,000 as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Intuitive Surgical by 1.1% in the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after purchasing an additional 360,591 shares in the last quarter. Geode Capital Management LLC grew its position in shares of Intuitive Surgical by 3.2% during the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after buying an additional 243,802 shares in the last quarter. Fisher Asset Management LLC increased its stake in shares of Intuitive Surgical by 1.8% during the fourth quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock valued at $2,541,356,000 after buying an additional 86,488 shares during the period. Norges Bank bought a new stake in shares of Intuitive Surgical in the fourth quarter valued at about $2,401,493,000. Finally, Invesco Ltd. lifted its stake in Intuitive Surgical by 7.7% in the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after acquiring an additional 295,025 shares during the period. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Intuitive Surgical stock traded up $12.56 during trading hours on Thursday, hitting $534.19. 1,965,145 shares of the stock traded hands, compared to its average volume of 1,672,340. The firm's 50 day moving average price is $530.03 and its 200-day moving average price is $536.86. The stock has a market capitalization of $191.46 billion, a price-to-earnings ratio of 78.33, a P/E/G ratio of 5.53 and a beta of 1.67. Intuitive Surgical, Inc. has a 1 year low of $413.82 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same quarter in the prior year, the firm earned $1.50 earnings per share. Research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have recently commented on ISRG. Truist Financial reduced their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a report on Wednesday, April 23rd. Robert W. Baird lowered their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Citigroup reiterated a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. BTIG Research set a $560.00 price objective on Intuitive Surgical and gave the stock a "buy" rating in a research note on Monday, April 14th. Finally, Evercore ISI dropped their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $588.95.

Insider Activity at Intuitive Surgical

In related news, SVP Mark Brosius sold 216 shares of the business's stock in a transaction on Friday, June 6th. The shares were sold at an average price of $563.11, for a total value of $121,631.76. Following the completion of the transaction, the senior vice president now directly owns 907 shares in the company, valued at $510,740.77. The trade was a 19.23% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Jami K. Nachtsheim sold 2,400 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $520.00, for a total transaction of $1,248,000.00. Following the sale, the director now owns 6,371 shares in the company, valued at approximately $3,312,920. This represents a 27.36% decrease in their position. The disclosure for this sale can be found here. Insiders sold 4,998 shares of company stock worth $2,611,577 over the last three months. Company insiders own 0.70% of the company's stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.